Pregnant women are among those most in need of safe and effective therapies against COVID-19, but they are routinely excluded from the majority of clinical treatment trials, according to authors of an opinion piece based ...
Dec 17, 2020
0
2
A study tracking seroprevalence across Iran suggests that the number of people who have had the SARS-CoV-2 virus is 17.1% overall and 20.0% in high-risk occupations. The findings suggest that an estimated almost 4.3 million ...
Dec 16, 2020
0
2
Black children hospitalised in the U.S. due to severe sepsis have 20% greater odds of death than White or Hispanic children, according to research published in The Lancet Child & Adolescent Health journal.
Dec 15, 2020
0
4
Phase 2 trials in 1,200 adults, young children, and infants suggest new poliovirus vaccine may have the potential to overcome outbreaks caused by a mutated polio strain linked to the oral vaccine that typically circulates ...
Dec 10, 2020
0
5
COVID-19 cases and outbreaks were low among staff and students in schools and nurseries in England that re-opened during the summer half-term after lockdown, according to research published in The Lancet Infectious Diseases ...
Dec 9, 2020
0
3
Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases—with vaccine efficacy of 62% for those given two full doses, and of 90% in those given a half ...
Dec 8, 2020
0
30
The measures may have limited impact on the epidemic within individual countries except those with low levels of the virus or that have strong travel links with countries experiencing high rates of infection.
Dec 8, 2020
0
2
Although SARS-CoV-2 genetic material may still be detected in respiratory or stool samples for several weeks, no live virus (that can cause infection) was found in any type of sample collected beyond nine days of symptoms ...
Nov 20, 2020
0
183
The UK's vaccine against SARS-CoV-2 shows similar safety and immunogenicity results in healthy older adults (aged 56 years and over) to those seen in adults aged 18-55 years. The promising early stage results are published ...
Nov 19, 2020
0
4
Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today in The Lancet Infectious Diseases journal, finding the formulation ...
Nov 18, 2020
0
3
